Login / Signup

Safety profile of upadacitinib in rheumatoid arthritis: integrated analysis from the SELECT phase III clinical programme.

Stanley B CohenRonald F Van VollenhovenKevin L WinthropCristiano A F ZerbiniYoshiya TanakaLouis BessetteYing ZhangNasser KhanBarbara HendricksonJeffrey V EnejosaGerd R Burmester
Published in: Annals of the rheumatic diseases (2020)
SELECT-EARLY: NCT02706873; SELECT-NEXT: NCT02675426; SELECT-COMPARE: NCT02629159; SELECT-MONOTHERAPY: NCT02706951; SELECT-BEYOND: NCT02706847.
Keyphrases
  • rheumatoid arthritis
  • phase iii
  • open label
  • clinical trial
  • randomized controlled trial
  • study protocol
  • ankylosing spondylitis
  • combination therapy